Clinically significant gastrointestinal disorders. Clinically significant gastrointestinal disorders History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug Clinically significant gastrointestinal conditions or disorders that may interfere with study drug absorption, including prior gastrectomy Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug. Clinically significant gastrointestinal conditions or disorders that may interfere with study drug absorption, including prior gastrectomy Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug Clinically significant gastrointestinal disorders Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents Patients who have gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug are not eligible History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug History of gastrointestinal disorders that may interfere with the absorption of study drug (including gastric bypass surgery) Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug Gastrointestinal disorders or abnormalities that would interfere with absorption of the study drug Gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug History of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of oral study drug(s) within months of enrollment History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug Clinically significant gastrointestinal disorders that may interfere with absorption of drug Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents Clinically significant gastrointestinal disorders that may interfere with absorption of drug. Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents Significant gastrointestinal disorders that may interfere with absorption of tosedostat. Gastrointestinal disorders that may significantly interfere with absorption of study drug History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug as determined by the investigator Patients with significantly diseased or obstructed gastrointestinal tract or uncontrolled vomiting or diarrhea or other gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents Significant gastrointestinal disorders, in the opinion of the Investigator Gastrointestinal disorders or abnormalities that would interfere with absorption of study drug Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents Patients with gastrointestinal disorders or abnormalities that would interfere with absorption of study treatment. Patients with a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agents Any gastrointestinal disorders which may interfere with the absorption of oseltamivir Gastrointestinal disorders that would interfere with drug absorption History of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of the study agent Gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of the study drug Have a history of gastrointestinal disorders (medical disorders or extensive surgery) that may interfere with the absorption of ranolazine History of gastrointestinal disorders (medical disorders or extensive surgery) which may interfere with the absorption of orally administered hormonal agents